# Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy

> **NCT01770431** · PHASE4 · COMPLETED · sponsor: **Qidong Gaitianli Medicines Co., Ltd** · enrollment: 1044 (actual)

## Conditions studied

- Hepatic Carcinoma

## Interventions

- **DRUG:** Huaier Granule

## Key facts

- **NCT ID:** NCT01770431
- **Lead sponsor:** Qidong Gaitianli Medicines Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 1044 (ACTUAL)
- **Last updated:** 2017-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01770431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01770431, "Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01770431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*